30 results
8-K
EX-1.1
HEPA
Hepion Pharmaceuticals Inc
17 Feb 21
Hepion Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
8:06am
of such prospectus.
“Applicable Time” means 6:15 a.m., Eastern time, on the date of this Agreement.
“Disclosure Package” means the Preliminary … notification that the Exchange is contemplating terminating such listing except as described in the Registration Statement, the Disclosure Package
424B5
HEPA
Hepion Pharmaceuticals Inc
16 Feb 21
Prospectus supplement for primary offering
5:11pm
and discuss the data generated for TXL to date, as well as the data package that would be required for the filing of an NDA and successful registration
424B5
HEPA
Hepion Pharmaceuticals Inc
16 Feb 21
Prospectus supplement for primary offering
6:03am
, to review and discuss the data generated for TXL to date, as well as the data package that would be required for the filing of an NDA and successful
8-K
EX-1.1
HEPA
Hepion Pharmaceuticals Inc
27 Nov 20
Hepion Pharmaceuticals Prices Public Offering
1:48pm
. As used herein, the terms “Registration Statement,” “ Preliminary Prospectus,” “Pricing Prospectus,” “Pricing Disclosure Package” and “Prospectus … Writing Prospectus.
“Pricing Disclosure Package” means any Issuer General Use Free Writing Prospectus issued at or prior to the Applicable Time
424B5
n636lo8 4q10na6o7gmh
26 Mar 20
Prospectus supplement for primary offering
9:33pm
424B5
47iwvtqgj6o397u7ij
12 Feb 20
Prospectus supplement for primary offering
9:05am
424B4
6fxn1fkk594hbg8g6h36
15 Jun 18
Prospectus supplement with pricing info
12:26pm
FWP
ue6vojp0iqn0u0xuqc
5 Jun 18
Free writing prospectus
4:31pm